Structural basis for synthase activation and cellulose modification in the E. coli Type II Bcs secretion system.

Autor: Anso I; Univ. Bordeaux, CNRS, Bordeaux INP, CBMN, UMR 5248, F-33600, Pessac, France.; Structural Biology of Biofilms Group, European Institute of Chemistry and Biology (IECB), 2 Rue Robert Escarpit, Pessac, F-33600, France.; Department of Biochemistry and Molecular Biology, Faculty of Science and Technology, University of the Basque Country (UPV/EHU), Barrio Sarriena s/n, 48940, Leioa, Spain., Zouhir S; Univ. Bordeaux, CNRS, Bordeaux INP, CBMN, UMR 5248, F-33600, Pessac, France.; Structural Biology of Biofilms Group, European Institute of Chemistry and Biology (IECB), 2 Rue Robert Escarpit, Pessac, F-33600, France.; Laboratoire de Biologie et Pharmacologie Appliquée (LBPA), CNRS UMR8113, ENS Paris-Saclay, Université Paris-Saclay, Gif-sur-Yvette, F-91190, France., Sana TG; Univ. Bordeaux, CNRS, Bordeaux INP, CBMN, UMR 5248, F-33600, Pessac, France.; Structural Biology of Biofilms Group, European Institute of Chemistry and Biology (IECB), 2 Rue Robert Escarpit, Pessac, F-33600, France., Krasteva PV; Univ. Bordeaux, CNRS, Bordeaux INP, CBMN, UMR 5248, F-33600, Pessac, France. pv.krasteva@iecb.u-bordeaux.fr.; Structural Biology of Biofilms Group, European Institute of Chemistry and Biology (IECB), 2 Rue Robert Escarpit, Pessac, F-33600, France. pv.krasteva@iecb.u-bordeaux.fr.

Publikováno v: Nature communications [Nat Commun] 2024 Oct 11; Vol. 15 (1), pp. 8799. Date of Electronic Publication: 2024 Oct 11.

The mycobacterial glycoside hydrolase LamH enables capsular arabinomannan release and stimulates growth.

Autor: Franklin A; School of Biosciences, University of Birmingham, Birmingham, UK., Salgueiro VC; Department of Preventive Medicine, Public Health and Microbiology, School of Medicine, Universidad Autonoma de Madrid, Madrid, Spain., Layton AJ; School of Biosciences, University of Birmingham, Birmingham, UK., Sullivan R; School of Biosciences, University of Birmingham, Birmingham, UK., Mize T; School of Biosciences, University of Birmingham, Birmingham, UK., Vázquez-Iniesta L; Department of Preventive Medicine, Public Health and Microbiology, School of Medicine, Universidad Autonoma de Madrid, Madrid, Spain., Benedict ST; School of Biosciences, University of Birmingham, Birmingham, UK., Gurcha SS; School of Biosciences, University of Birmingham, Birmingham, UK., Anso I; Structural Glycobiology Laboratory, Department of Structural and Molecular Biology, Molecular Biology Institute of Barcelona, Spanish National Research Council, Barcelona Science Park, c/Baldiri Reixac 10-12, Tower R, 08028, Barcelona, Catalonia, Spain., Besra GS; School of Biosciences, University of Birmingham, Birmingham, UK., Banzhaf M; School of Biosciences, University of Birmingham, Birmingham, UK., Lovering AL; School of Biosciences, University of Birmingham, Birmingham, UK., Williams SJ; School of Chemistry and Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, VIC, Australia., Guerin ME; Structural Glycobiology Laboratory, Department of Structural and Molecular Biology; Molecular Biology Institute of Barcelona (IBMB), Spanish National Research Council (CSIC), Barcelona, Catalonia, Spain., Scott NE; Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia., Prados-Rosales R; Department of Preventive Medicine, Public Health and Microbiology, School of Medicine, Universidad Autonoma de Madrid, Madrid, Spain., Lowe EC; Newcastle University Biosciences Institute, Medical School, Newcastle University, Newcastle upon Tyne, UK. elisabeth.lowe@ncl.ac.uk., Moynihan PJ; School of Biosciences, University of Birmingham, Birmingham, UK. p.j.moynihan@bham.ac.uk.

Publikováno v: Nature communications [Nat Commun] 2024 Jul 09; Vol. 15 (1), pp. 5740. Date of Electronic Publication: 2024 Jul 09.

Acylation of glycerolipids in mycobacteria.

Autor: Angala SK; Mycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO, 80523-1682, USA., Carreras-Gonzalez A; Unidad de Biofisica, Centro Mixto Consejo Superior de Investigaciones Cientificas - Universidad del País Vasco/Euskal Herriko Unibertsitatea (CSIC-UPV/EHU), Barrio Sarriena s/n, Leioa, Bizkaia, 48940, Spain.; Departamento de Bioquímica, Universidad del País Vasco, Leioa, Spain., Huc-Claustre E; Mycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO, 80523-1682, USA., Anso I; Structural Glycobiology Laboratory, Biocruces Bizkaia Health Research Institute, Cruces University Hospital, Barakaldo, Bizkaia, 48903, Spain., Kaur D; Mycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO, 80523-1682, USA.; New England Newborn Screening Program, University of Massachusetts Medical School, Worcester, MA, 01605, USA., Jones V; Mycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO, 80523-1682, USA., Palčeková Z; Mycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO, 80523-1682, USA., Belardinelli JM; Mycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO, 80523-1682, USA., de Sousa-d'Auria C; Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), Gif-sur-Yvette, France., Shi L; Mycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO, 80523-1682, USA., Slama N; Institut de Pharmacologie et de Biologie Structurale (IPBS), CNRS, UPS, Université Toulouse III - Paul Sabatier, Toulouse, France., Houssin C; Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), Gif-sur-Yvette, France., Quémard A; Institut de Pharmacologie et de Biologie Structurale (IPBS), CNRS, UPS, Université Toulouse III - Paul Sabatier, Toulouse, France., McNeil M; Mycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO, 80523-1682, USA., Guerin ME; Unidad de Biofisica, Centro Mixto Consejo Superior de Investigaciones Cientificas - Universidad del País Vasco/Euskal Herriko Unibertsitatea (CSIC-UPV/EHU), Barrio Sarriena s/n, Leioa, Bizkaia, 48940, Spain.; Departamento de Bioquímica, Universidad del País Vasco, Leioa, Spain.; Structural Glycobiology Laboratory, Biocruces Bizkaia Health Research Institute, Cruces University Hospital, Barakaldo, Bizkaia, 48903, Spain.; IKERBASQUE, Basque Foundation for Science, 48009, Bilbao, Spain.; Structural Glycobiology Laboratory, Department of Structural and Molecular Biology, Molecular Biology Institute of Barcelona (IBMB), Spanish National Research Council (CSIC), Barcelona Science Park, c/Baldiri Reixac 4-8, Tower R, 08028, Barcelona, Catalonia, Spain., Jackson M; Mycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO, 80523-1682, USA. Mary.Jackson@colostate.edu.

Publikováno v: Nature communications [Nat Commun] 2023 Oct 23; Vol. 14 (1), pp. 6694. Date of Electronic Publication: 2023 Oct 23.

Raman Spectroscopy as a Tool to Study the Pathophysiology of Brain Diseases.

Autor: Terrones O; Department of Biochemistry and Molecular Biology, Faculty of Science and Technology, University of the Basque Country (UPV/EHU), Barrio Sarriena s/n, 48940 Leioa, Spain., Olazar-Intxausti J; Department of Biochemistry and Molecular Biology, Faculty of Science and Technology, University of the Basque Country (UPV/EHU), Barrio Sarriena s/n, 48940 Leioa, Spain., Anso I; Department of Biochemistry and Molecular Biology, Faculty of Science and Technology, University of the Basque Country (UPV/EHU), Barrio Sarriena s/n, 48940 Leioa, Spain.; Structural Glycobiology Laboratory, Biocruces Bizkaia Health Research Institute, Cruces University Hospital, 48903 Barakaldo, Spain., Lorizate M; Department of Biochemistry and Molecular Biology, Faculty of Science and Technology, University of the Basque Country (UPV/EHU), Barrio Sarriena s/n, 48940 Leioa, Spain., Nieto-Garai JA; Department of Biochemistry and Molecular Biology, Faculty of Science and Technology, University of the Basque Country (UPV/EHU), Barrio Sarriena s/n, 48940 Leioa, Spain., Contreras FX; Department of Biochemistry and Molecular Biology, Faculty of Science and Technology, University of the Basque Country (UPV/EHU), Barrio Sarriena s/n, 48940 Leioa, Spain.; Instituto Biofisika (UPV/EHU, CSIC), Barrio Sarriena s/n, 48940 Leioa, Spain.; Ikerbasque, Basque Foundation of Science, 48011 Bilbao, Spain.

Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2023 Jan 25; Vol. 24 (3). Date of Electronic Publication: 2023 Jan 25.

Molecular ruler mechanism and interfacial catalysis of the integral membrane acyltransferase PatA.

Autor: Anso I; Structural Glycobiology Laboratory, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, Building 801A, 48160 Derio, Spain.; Structural Glycobiology Laboratory, Biocruces Bizkaia Health Research Institute, Cruces University Hospital, 48903 Barakaldo, Bizkaia, Spain., Basso LGM; Laboratório de Ciências Físicas, Centro de Ciência e Tecnologia, Universidade Estadual do Norte Fluminense Darcy Ribeiro, Avenida Alberto Lamego, 2000, Campos dos Goytacazes, 28013-602 Rio de Janeiro, Brazil.; Laboratório de Biofísica Molecular, Departamento de Física, Faculdade de Filosofia, Ciências e Letras de Ribeirão Preto, Universidade de São Paulo, Avenida Bandeirantes, 3900, 14040-901 Ribeirão Preto, São Paulo, Brazil., Wang L; Department of Chemistry, University of Alberta, Edmonton, Alberta, T6G 2G2, Canada., Marina A; Structural Glycobiology Laboratory, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, Building 801A, 48160 Derio, Spain., Páez-Pérez ED; Structural Glycobiology Laboratory, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, Building 801A, 48160 Derio, Spain.; IPICYT, División de Biología Molecular, Instituto Potosino de Investigación Científica y Tecnológica A.C., San Luis Potosí, México., Jäger C; Luxembourg Centre for Systems Biomedicine, University of Luxembourg, L-4367 Belvaux, Luxembourg., Gavotto F; Luxembourg Centre for Systems Biomedicine, University of Luxembourg, L-4367 Belvaux, Luxembourg., Tersa M; Structural Glycobiology Laboratory, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, Building 801A, 48160 Derio, Spain., Perrone S; Structural Glycobiology Laboratory, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, Building 801A, 48160 Derio, Spain.; Structural Glycobiology Laboratory, Biocruces Bizkaia Health Research Institute, Cruces University Hospital, 48903 Barakaldo, Bizkaia, Spain.; Luxembourg Centre for Systems Biomedicine, University of Luxembourg, L-4367 Belvaux, Luxembourg., Contreras FX; Instituto Biofisika, Consejo Superior de Investigaciones Científicas, Universidad del País Vasco/Euskal Herriko Unibertsitatea (CSIC,UPV/EHU), Barrio Sarriena s/n, Leioa, 48940 Bizkaia, Spain.; Departamento de Bioquímica, Universidad del País Vasco, Leioa, 48940 Bizkaia, Spain.; IKERBASQUE, Basque Foundation for Science, 48013 Bilbao, Spain., Prandi J; Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse, CNRS, UPS, 205 route de Narbonne, F-31077 Toulouse, France., Gilleron M; Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse, CNRS, UPS, 205 route de Narbonne, F-31077 Toulouse, France., Linster CL; Luxembourg Centre for Systems Biomedicine, University of Luxembourg, L-4367 Belvaux, Luxembourg., Corzana F; Departamento Química and Centro de Investigación en Síntesis Quı́mica, Universidad de La Rioja, 26006 Rioja, Spain., Lowary TL; Department of Chemistry, University of Alberta, Edmonton, Alberta, T6G 2G2, Canada.; Institute of Biological Chemistry, Academia Sinica, Academia Road, Section 2, #128, Nangang, Taipei 11529, Taiwan.; Institute of Biochemical Sciences, National Taiwan University, Section 4, #1, Roosevelt Road, Taipei 10617, Taiwan., Trastoy B; Structural Glycobiology Laboratory, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, Building 801A, 48160 Derio, Spain.; Structural Glycobiology Laboratory, Biocruces Bizkaia Health Research Institute, Cruces University Hospital, 48903 Barakaldo, Bizkaia, Spain., Guerin ME; Structural Glycobiology Laboratory, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, Building 801A, 48160 Derio, Spain.; Structural Glycobiology Laboratory, Biocruces Bizkaia Health Research Institute, Cruces University Hospital, 48903 Barakaldo, Bizkaia, Spain.; IKERBASQUE, Basque Foundation for Science, 48013 Bilbao, Spain.

Publikováno v: Science advances [Sci Adv] 2021 Oct 15; Vol. 7 (42), pp. eabj4565. Date of Electronic Publication: 2021 Oct 15.